Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
View Patent ↗Polyaminofunctional alkoxy polysiloxanes which exhibit antineoplastic activity are disclosed. Pharmaceutical compositions including an effective amount of a polyaminofunctional alkoxy polysiloxane and/or a pharmaceutically acceptable salt thereof are also disclosed. The application also describes methods of suppressing the growth of neoplastic cells and treating neoplastic conditions.
1. An aminofunctional alkoxy polysiloxane having the formula:
wherein n is an integer from 2 to 1,000; m is an integer from 0 to 1,000; and at least about 20% of the siloxane subunits include a polyaminofunctional alkoxy group;
R 1 , R 2 , and R 3 are independently C 1 - C 10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;
R 4 is C 1 - C 10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;
R 14 is hydrogen, C1- C10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;
R 15 is C 1 - C 10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl, or an alkoxy group; and
R 5 is
wherein R 6 , R 7 , R 8 , and R 9 are independently hydrogen or C 1 - C 6 alkyl, or R 6 and R 7 form a C 3 - C 8 cyclic group or R 8 and R 9 form a C 3 - C 8 cyclic group.
2. The polysiloxane of claim 1 , wherein m is 0.
3. The polysiloxane of claim 1 , wherein m is 0 and n is 2.
4. The polysiloxane of claim 1 , wherein m + n is from 2 to about 100.
5. The polysiloxane of claim 1 , wherein R 1 , R 2 , R 3 , R 4 , R 14 and R 15 are C 1 -C 6 alkyl.
6. The polysiloxane of claim 1 , wherein R 1 , R 2 , R 3 , R 4 , R 14 and R 15 are methyl.
7. The polysiloxane of claim 1 , wherein R 5 is
8. The polysiloxane of claim 1 , wherein m is 0; n is an integer from 2 to 50; and R 5 is
9. The polysiloxane of claim 1 , wherein m is 0; R 1 , R 2 , R 3 , R 4 , R 14 and R 15 are methyl; and R 5 is
10. The polysiloxane of claim 1 , wherein R 6 , R 7 , R 8 , and R 9 are C 1 - C 6 alkyl.
11. The polysiloxane of claim 10 , wherein R 1 , R 2 , R 3 , R 4 , R 14 and R 15 are methyl.
12. An aminofunctional alkoxy polysiloxane having the formula:
wherein n is an integer from 2 to 1,000; m is an integer from 0 to 1,000; and at least about 20% of the siloxane subunits include a polyaminofunctional alkoxy group;
R 1 , R 2 and R 3 are independently C 1 - C 10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;
R 4 is C 1 - C 10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;
R 14 is hydrogen, C 1 - C 10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl or phenyl;
R 15 is C 1 - C 10 alkyl, cyclopentyl, cyclohexyl, benzyl, toluyl, xylyl, phenyl, or an alkoxy group; and
R 5 is -O-CH 2 CH 2 NR 10 (CH 2 ) q NR 11 R 12 ; and q is 2 or 3; and R 10 is hydrogen or C 1 - C 6 alkyl; and R 11 and R 12 are independently C 1 - C 6 alkyl, or R 11 and R 12 form a C 3 - C 8 cyclic group.
13. The polysiloxane of claim 12 , wherein q is 2.
14. The polysiloxane of claim 12 , wherein q is 3.
15. The polysiloxane of claim 12 , wherein R 10 is C 1 -C 6 alkyl; and R 11 and R 12 are independently C 1 - C 6 alkyl.
16. The polysiloxane of claim 12 , wherein R 11 and R 12 are methyl.
17. The polysiloxane of claim 12 , wherein R 5 is —OCH 2 CH 2 NHCH 2 CH 2 NMe 2 .
18. The polysiloxane of claim 12 , wherein R 5 is —OCH 2 CH 2 NMeCH 2 CH 2 NMe 2 .
19. The polysiloxane of claim 12 , wherein R 10 is hydrogen.
20. The polysiloxane of claim 12 , wherein R 10 is methyl
21. The polysiloxane of claim 12 , wherein m is 0.
22. The polysiloxane of claim 12 , wherein m is 0 and n is 2.
23. The polysiloxane of claim 12 , wherein m + n is from 2 to about 100.
24. The polysiloxane of claim 12 , wherein the polysiloxane is a random copolymer.
25. The polysiloxane of claim 12 , wherein R 5 is —OCH 2 CH 2 NMeCH 2 CH 2 CH 2 NMe 2 .